Inoviq Ltd has released a press release.
INOVIQ Engages ResearchDX to Develop & Validate SubB2M-Tests
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from Inoviq
- INOVIQ & UQ Collaborate on Exosome-based Ovarian Cancer Test
- Update on Legal Proceedings and BARD1 Autoantibody Program
- Brazilian Patent Issued for Lung & Colorectal Cancer
- Appendix 4C & Quarterly Activities Report
- AGM Presentation
Later from Inoviq
- IIQ Appendix 4C & Quarterly Activities Report - March 2022
- INOVIQ Key Manufacturing Agreement to Advance SubB2M tests
- Australian Patent Granted for SubB2M Technology
- SubB2M US Patent Grant and Program Update
- INOVIQ Engages Sales Team to Accelerate EXO-NET Roll-out
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq